Insights

Recent Acquisitions Covis Pharma has recently acquired US rights for multiple drugs from Sanofi and global rights to Duaklir and Eklira from AstraZeneca, indicating a strong focus on expanding its product portfolio. This presents a prime opportunity for cross-selling and upselling to existing and new customers.

Strategic Partnerships The partnership with the FDA showcases Covis Pharma's commitment to regulatory compliance and quality standards. Leveraging this collaboration can open doors for collaborative sales initiatives, access to new markets, and enhanced credibility with healthcare providers.

Executive Appointments The recent appointments of key executives like Christine Poulin, Michelle Lock, and Sandy Loreaux signal a potential shift in sales strategies and market approach. Engaging with these new leaders could lead to innovative sales tactics, targeted customer engagement, and customized sales solutions.

Financial Stability With a revenue between $50M - $100M, Covis Pharma demonstrates financial strength and stability in the pharmaceutical market. This financial standing provides confidence to potential buyers, and partnering with a financially secure company can be advantageous in securing long-term sales relationships.

Peer Landscape Comparison When benchmarked against similar pharmaceutical companies like Amneal Pharmaceuticals, Hikma Pharmaceuticals, and Sandoz, Covis Pharma's positioning with a revenue in the range of $50M - $100M offers a competitive edge. Identifying gaps in competitors' offerings and addressing customer needs better can lead to increased market share and sales growth.

Covis Pharma Tech Stack

Covis Pharma uses 8 technology products and services including Complianz, WordPress, jQuery, and more. Explore Covis Pharma's tech stack below.

  • Complianz
    A/B Testing
  • WordPress
    Content Management System
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • HTTP/3
    Miscellaneous
  • jQuery Mobile
    Mobile Frameworks
  • Contact Form 7
    Web Platform Extensions
  • Popup Maker
    Web Platform Extensions

Media & News

Covis Pharma's Email Address Formats

Covis Pharma uses at least 1 format(s):
Covis Pharma Email FormatsExamplePercentage
FLast@covispharma.comJDoe@covispharma.com
50%
FLast@covispharma.comJDoe@covispharma.com
50%

Frequently Asked Questions

Where is Covis Pharma's headquarters located?

Minus sign iconPlus sign icon
Covis Pharma's main headquarters is located at Grafenauweg 12 Zug, 6300 CH. The company has employees across 2 continents, including North AmericaEurope.

What is Covis Pharma's official website and social media links?

Minus sign iconPlus sign icon
Covis Pharma's official website is covispharma.com and has social profiles on LinkedIn.

How much revenue does Covis Pharma generate?

Minus sign iconPlus sign icon
As of September 2024, Covis Pharma's annual revenue reached $75M.

What is Covis Pharma's SIC code NAICS code?

Minus sign iconPlus sign icon
Covis Pharma's SIC code is 2899 - Chemicals and Chemical Preparations, Not Elsewhere Classified NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does Covis Pharma have currently?

Minus sign iconPlus sign icon
As of September 2024, Covis Pharma has approximately 558 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: J. L.Chief Executive Officer: M. G.Chief Operating Officer: C. S.. Explore Covis Pharma's employee directory with LeadIQ.

What industry does Covis Pharma belong to?

Minus sign iconPlus sign icon
Covis Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Covis Pharma use?

Minus sign iconPlus sign icon
Covis Pharma's tech stack includes ComplianzWordPressjQueryjQuery MigrateHTTP/3jQuery MobileContact Form 7Popup Maker.

What is Covis Pharma's email format?

Minus sign iconPlus sign icon
Covis Pharma's email format typically follows the pattern of . Find more Covis Pharma email formats with LeadIQ.

When was Covis Pharma founded?

Minus sign iconPlus sign icon
Covis Pharma was founded in 2011.
Covis Pharma

Covis Pharma

Pharmaceutical ManufacturingZug, Switzerland501-1000 Employees

Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses. Our purpose is to turn untapped potential into global medical therapies that improve our patients' lives. Apollo Global Management, with $455 billion AUM, is the private equity sponsor of Covis Pharma.

Section iconCompany Overview

Headquarters
Grafenauweg 12 Zug, 6300 CH
SIC Code
2899 - Chemicals and Chemical Preparations, Not Elsewhere Classified
NAICS Code
325412 - Pharmaceutical Preparation Manufacturing
Founded
2011
Employees
501-1000

Section iconFunding & Financials

  • $50M$100M

    Covis Pharma's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Covis Pharma's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.